Detalles de la búsqueda
1.
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.
Lancet Oncol
; 16(8): 949-56, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26179200
2.
Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients.
Clin Chem
; 55(7): 1354-60, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19406916
3.
What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?
Eur J Cancer
; 45(17): 2984-91, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19646862
4.
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
J Clin Oncol
; 26(4): 592-8, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18235117
Resultados
1 -
4
de 4
1
Próxima >
>>